This morning’s newspaper about Rezulin, the medication that was taken out of the type 2 diabetes prevention study because it was implicated in the death of a subject. The article, dated July 28, 1998, with a Washington, D.C. byline, states that seven months after being banned in Great Britain because of its liver risks, consumer …
-
Subscribe
Subscribed
Already have a WordPress.com account? Log in now.
Diabetes Research 